Abstract
Metabolic regulation is largely dependent on mitochondria, which play an important role in energy homeostasis. Mitochondrial dysfunction results in an imbalanced energy supply to the cell, which may compromise its survival. Due to the role of mitochondrial factors/events in several apoptotic pathways, the possibility of targeting that organelle in the tumor cell, leading to its elimination is very attractive, although the safety issue is problematic. Berberine, a benzyl-tetra isoquinoline alkaloid extracted from plants of the Berberidaceae family, has been extensively used for many centuries, especially in the traditional Chinese and Native American medicine. Several evidences suggest that berberine possesses several therapeutic uses, including anti-tumoral activity. The present review supplies evidence that berberine is a safe anti-cancer agent, exerting several effects on mitochondria, including inhibition of mitochondrial Complex I and interaction with the adenine nucleotide translocator which can explain several of the described effects on tumor cells.
Keywords: Berberine, cancer, anti-cancer agents, mitochondria, safety, pharmacology, apotosis, cell cycle, ATP, Resveratrol
Current Drug Targets
Title: Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Volume: 12 Issue: 6
Author(s): Catia V. Diogo, Nuno G. Machado, Ines A. Barbosa, Teresa L. Serafim, Ana Burgeiro and Paulo J. Oliveira
Affiliation:
Keywords: Berberine, cancer, anti-cancer agents, mitochondria, safety, pharmacology, apotosis, cell cycle, ATP, Resveratrol
Abstract: Metabolic regulation is largely dependent on mitochondria, which play an important role in energy homeostasis. Mitochondrial dysfunction results in an imbalanced energy supply to the cell, which may compromise its survival. Due to the role of mitochondrial factors/events in several apoptotic pathways, the possibility of targeting that organelle in the tumor cell, leading to its elimination is very attractive, although the safety issue is problematic. Berberine, a benzyl-tetra isoquinoline alkaloid extracted from plants of the Berberidaceae family, has been extensively used for many centuries, especially in the traditional Chinese and Native American medicine. Several evidences suggest that berberine possesses several therapeutic uses, including anti-tumoral activity. The present review supplies evidence that berberine is a safe anti-cancer agent, exerting several effects on mitochondria, including inhibition of mitochondrial Complex I and interaction with the adenine nucleotide translocator which can explain several of the described effects on tumor cells.
Export Options
About this article
Cite this article as:
V. Diogo Catia, G. Machado Nuno, A. Barbosa Ines, L. Serafim Teresa, Burgeiro Ana and J. Oliveira Paulo, Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?, Current Drug Targets 2011; 12 (6) . https://dx.doi.org/10.2174/138945011795528930
DOI https://dx.doi.org/10.2174/138945011795528930 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in the Use of Metallic Nanoparticles with Antitumoral Action - Review
Current Medicinal Chemistry Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines
Anti-Cancer Agents in Medicinal Chemistry New Cathepsin D Inhibitor Library Utilizing Hydroxyethyl Isosteres with Cyclic Tertiary Amines
Medicinal Chemistry Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis
Current Topics in Medicinal Chemistry Development of a High Throughput Drug Screening Assay for the Detection of Changes in Tau Levels - Proof of Concept with HSP90 inhibitors
Current Alzheimer Research Latest Results for Anti-Angiogenic Drugs in Cancer Treatment
Current Pharmaceutical Design Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target
Current Cancer Therapy Reviews Meet Our Editorial Board Member:
Current Medicinal Chemistry Synthesis, Characterization, Biological Evaluation and Molecular Docking Studies of New Oxoacrylate and Acetamide on HeLa Cancer Cell Lines
Current Computer-Aided Drug Design Application of Nanobioinformatics in Medical Science – A Probable Therapy
Current Bioinformatics Cancer Chemoprevention by Dietary Phytochemicals: Promises and Pitfalls
Current Pharmaceutical Biotechnology Histone Deacetylase Inhibitors as Potent Modulators of Cellular Contacts
Current Drug Targets Fgf10: A Paracrine-Signaling Molecule in Development, Disease, and Regenerative Medicine
Current Molecular Medicine Fused Xanthone Derivatives as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Role of the heme oxygenase-adiponectin-atrial natriuretic peptide axis in renal function
Current Pharmaceutical Design Novel Strategies to Ameliorate Radiation Injury: A Possible Role for Tetrahydrobiopterin
Current Drug Targets Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
Current Pharmaceutical Design Current State of Development of Genome Analysis in Livestock
Current Genomics